OBO ID: CHEBI:3286

Term Name:	cabergoline		Search Ontology:
Synonyms:	(8beta)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide (8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide 1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea 1-[(6-allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea 1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea cabergolina cabergoline cabergolinum
Definition:	An N-acylurea that is (8R)-ergoline-8-carboxamide in which the hydrogen attached to the piperidine nitrogen (position 6) is substituted by an allyl group and the hydrogens attached to the carboxamide nitrogen are substituted by a 3-(dimethylamino)propyl group and an N-ethylcarbamoyl group. A dopamine D2 receptor agonist, cabergoline is used in the management of Parkinson's disease and of disorders associated with hyperprolactinaemia.
References:	Beilstein:6020775 CAS:81409-90-7 DrugBank:DB00248 Drug_Central:460 HMDB:HMDB0014393 KEGG:C08187 KEGG:D00987 LINCS:LSM-3939 PMID:22075008 PMID:22336848 PMID:22740242 PMID:23110560 PMID:23743769 Patent:BE888243 Patent:US4526892 VSDB:1830 Wikipedia:Cabergoline
Ontology:	ChEBI  ( EBI )